In this article, we are going to take a look at where ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) stands against other Friday’s top performers. The stock market finished the trading week in the ...

ACADIA PHARMACEUTICALS ($ACAD) posted quarterly earnings results on Wednesday, May 7th. The company reported earnings of $0.11 per share, missing estimates of $0.11 ...

Fintel reports that on May 21, 2025, Deutsche Bank upgraded their outlook for ACADIA Pharmaceuticals (NasdaqGS:ACAD) from Hold to Buy. Analyst Price Forecast Suggests 13.02% Upside As of May 6, 2025, ...

Fintel reports that on May 21, 2025, Deutsche Bank upgraded their outlook for ACADIA Pharmaceuticals ... options sentiment, insider trading, options flow, unusual options trades, and much more.

Forget the unicorn hunt. Outperformance lives in evidence-based asymmetry, mispriced assets, and free options the market ...

Across the recent three months, 11 analysts have shared their insights on ACADIA Pharmaceuticals ACAD, expressing a variety ...

"attachment_1202489" align="aligncenter" width="1456"] A research scientist looking through a microscope in a lab, ...

On Wednesday, BofA Securities analysts increased the price target for Acadia Pharmaceuticals stock (NASDAQ: ACAD) to $23 from $18, while maintaining a Neutral rating. The company, which has shown ...

ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD – Get Free Report) saw unusually large options trading activity on Thursday.Stock traders purchased 2,626 call options on the company. This is an ...